
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PIGR (Polymeric Immunoglobulin Receptor):** Involved in immune response, particularly in transporting immunoglobulins across epithelial cells.<br>- **ALDH1A3 (Aldehyde Dehydrogenase 1 Family Member A3):** Associated with stem cell properties and detoxification processes.<br>- **SAA1/SAA2 (Serum Amyloid A1/A2):** Acute-phase proteins involved in inflammation.<br>- **CXCL1/CXCL2/CXCL3/CXCL8 (Chemokine Ligands):** Involved in chemotaxis and inflammatory responses.<br>- **MMP7 (Matrix Metallopeptidase 7):** Involved in the breakdown of extracellular matrix, important in tissue remodeling and cancer metastasis.<br>- **SOD2 (Superoxide Dismutase 2):** Protects against oxidative stress.<br>- **MT2A/MT1X (Metallothioneins):** Involved in metal ion homeostasis and detoxification.<br>- **S100A9/S100A6/S100A16 (S100 Calcium Binding Proteins):** Involved in regulation of a variety of cellular processes such as cell cycle progression and differentiation.<br>- **CCL20 (C-C Motif Chemokine Ligand 20):** Involved in immune cell trafficking.<br>- **LTF (Lactotransferrin):** Involved in immune response and iron binding.<br>- **BIRC3 (Baculoviral IAP Repeat Containing 3):** Involved in inhibiting apoptosis.<br>- **TNFRSF12A (Tumor Necrosis Factor Receptor Superfamily Member 12A):** Involved in inflammation and apoptosis.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT7 (Keratin 7):** Typically expressed in epithelial cells, particularly glandular and transitional epithelia.<br>- **KRT23 (Keratin 23):** Associated with epithelial cells.<br>- **ANXA1/ANXA3 (Annexins):** Involved in membrane-related events along exocytotic and endocytotic pathways, often found in epithelial cells.<br>- **LCN2 (Lipocalin 2):** Involved in innate immunity and often expressed in epithelial cells.<br>- **SLPI (Secretory Leukocyte Peptidase Inhibitor):** Expressed in epithelial tissues, involved in protecting epithelial surfaces from proteolytic attack.<br>- **WFDC2 (WAP Four-Disulfide Core Domain 2):** Also known as HE4, a marker for epithelial cells, particularly in ovarian and breast tissues.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers. Many of these markers are associated with epithelial cells, particularly those involved in immune response and inflammation, which are common in cancerous tissues.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers such as KRT7, KRT23, ANXA1, and WFDC2, the most probable general cell type is **epithelial cells**. These markers are commonly expressed in epithelial tissues, and their presence in breast cancer tissue suggests an epithelial origin.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells:** Given the expression of KRT7 and WFDC2, which are often found in luminal epithelial cells of the breast.<br>2. **Basal Epithelial Cells:** Some markers like S100A9 and S100A6 can also be expressed in basal epithelial cells, which are involved in structural support and regeneration.<br>3. **Cancer-associated Epithelial Cells:** The presence of inflammation and immune response markers like SAA1, CXCL1, and CCL20 suggests a cancer-associated epithelial phenotype, which is common in breast cancer tissues.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The cluster of cells from the breast cancer tissue is most likely composed of epithelial cells, with a high probability of being luminal epithelial cells. The expression of immune and inflammation-related markers suggests an active role in the tumor microenvironment, possibly indicating a cancer-associated epithelial phenotype. The top three subtypes are luminal epithelial cells, basal epithelial cells, and cancer-associated epithelial cells, with luminal epithelial cells being the most likely subtype.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers such as KRT7, KRT23, ANXA1, and WFDC2 are indeed associated with epithelial cells, supporting the annotation of epithelial cell types.<br>   - The presence of immune and inflammation-related markers like SAA1, CXCL1, and CCL20 aligns with the cancer-associated epithelial phenotype, which is common in breast cancer tissues.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of mixed cell types by identifying subtypes such as luminal epithelial cells, basal epithelial cells, and cancer-associated epithelial cells. This is appropriate given the expression of various markers that can be associated with different epithelial subtypes.<br><br>Overall, the annotation is well-supported by the marker list and the analysis provided. The identification of epithelial cells, particularly luminal epithelial cells, is consistent with the expression of the markers and the context of breast cancer tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">epithelial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>luminal epithelial cells</li><li>basal epithelial cells</li><li>cancer-associated epithelial cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the marker list and its implications for identifying cell types within the context of human breast cancer. The analysis effectively identifies epithelial cells as the main cell type, which is consistent with the presence of markers such as KRT7, KRT23, ANXA1, and WFDC2. These markers are well-known to be associated with epithelial cells, particularly in glandular tissues like the breast.<br><br>The annotation also appropriately considers the presence of immune and inflammation-related markers (e.g., SAA1, CXCL1, CCL20), which are relevant in the context of cancer-associated epithelial cells. This indicates a comprehensive approach to understanding the tumor microenvironment and the potential roles of these cells in cancer progression.<br><br>The identification of subtypes, including luminal epithelial cells, basal epithelial cells, and cancer-associated epithelial cells, reflects a balanced consideration of the marker list. The analysis does not overly focus on a single marker but instead integrates multiple markers to provide a nuanced view of the cell populations present. This is crucial in single-cell annotation, where heterogeneity is common.<br><br>However, while the annotation is generally accurate, it could benefit from a more explicit discussion of the rank and importance of the markers. For instance, PIGR, which appears first in the list, is noted for its role in immune response but is not emphasized as much in the final annotation. A more detailed explanation of how the rank of markers influenced the final cell type determination would strengthen the analysis.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present in the data. There are no obvious misclassifications, and the analysis captures the general picture effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    